Aligos Therapeutics to Present at the SVB Securities Global Biopharma Conference

February 10, 2023

https://www.globenewswire.com/news-release/2023/02/10/2605819/0/en/Aligos-Therapeutics-to-Present-at-the-SVB-Securities-Global-Biopharma-Conference.html

SOUTH SAN FRANCISCO, Calif., Feb. 10, 2023 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq:ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in NASH and viral diseases, today announced that Lawrence M. Blatt, Ph.D., MBA, Chairman and CEO of Aligos, will present at the virtual SVB Securities Global Biopharma Conference on Wednesday, February 15, 2023 at 5:00 p.m. ET.

Read more at globenewswire.com

Related news for (ALGS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.